The global in vitro fertilization market in terms of revenue was estimated to be worth $638 million in 2021 and is poised to reach $987 million by 2026, growing at a CAGR of 9.1% from 2021 to 2026. The new research study consists of an industry trend analysis of the market.

The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

The newly added segments are expected to provide more in-depth insights into regional as well as country-level markets for various product segments. Growth factors for this market include greater public awareness about infertility and the availability of treatment options. However, the high cost and low success rate of in vitro fertilization treatments, as well as restrictive regulations and ethical concerns, are expected to restrict the growth of the market to a certain extent. 

In vitro fertilization (IVF) is a process of assisted reproductive technology in which a woman’s eggs are surgically removed from her ovaries and fertilized with sperm in a laboratory.

The fertilized egg is then transferred back into the woman’s uterus, resulting in a successful pregnancy. While in vitro fertilization is an effective means of helping many couples conceive, the procedure is expensive and often not covered by health insurance.

The cost of an in vitro fertilization cycle can range from $10,000 to $15,000, depending on factors such as the age of the woman and the complexity of the procedure. Additionally, medications used during the process can also add to the cost. This high cost can be a major barrier for many couples considering in vitro fertilization.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89198891 

The rise in number of  IVF with ICSI procedure to support the market growth during the forecast period.

The success rate of fertilization with ICSI procedure and the growing utilization of the ICSI during IVF procedure are anticipated to boost the adoption of IVF with ICSI procedures, accelerating the growth of the segment during the forecast period. Moreover, the growing focus of players in expanding their product offerings in ICSI  is anticipated to contribute towards the rapid adoption of IVF with ICSI procedures during the forecast period.

Asia Pacific likely to emerge as the fastest-growing in vitro fertilization market, globally.

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 10.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the in vitro fertilization market in the region.

Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US), among others